Published in Pharma Investments, Ventures and Law Weekly, September 18th, 2005
Investigators in the Netherlands conducted a study "to evaluate the efficacy of radiotherapy in patients with GBM with a limited prognosis and in patients older than 70 years. Retrospective analysis of 202 patients with GBM treated between 1990 and 2000 in a single institution [was performed]."
"Patients (including patients {{>=}}70 years) were assigned to RPA groups and their survival was compared with RTOG data. Median survival was 8.0 months for the total group and 13.9, 10.6, 3.8, 2.1 months for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.